Inspire Medical Systems Stock News

MINNEAPOLIS, April 05, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative,

Although oil futures traded higher on Wednesday, there were a few notable insider trades. When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock

This week, Motley Fool analyst Yasser El-Shimy makes his impressive Market Cap Game Show debut.

Many healthcare stocks have been outperforming the market averages this year. Here are three stocks our roundtable likes.

Inspire Medical Systems Inc (NYSE: INSP ) generated revenue of $78.39 million in Q4, a 70% Y/Y increase , marginally beating the consensus of $78.11 million and in line with the management expectation . U.S. revenue increased 77% to $$75.6 million, and revenue outside of the U.S. was $2.8 million, a decrease of 13%. The gross margin increased to 85.8% from 84.4% Full story available on Benzinga.com

Inspire Medical Systems Inc INSP generated revenue of $78.39 million in Q4, a 70% Y/Y increase, marginally beating the consensus of $78.11 million and in line with the management expectation. Get t

Inspire Medical Systems, Inc. (NYSE:INSP) Q4 2021 Earnings Conference Call February 8, 2022 05:00 p.m.

Inspire Medical Systems, Inc. (INSP) CEO Tim Herbert on Q4 2021 Results - Earnings Call Transcript

Inspire (INSP) delivered earnings and revenue surprises of 80.85% and 0.27%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Inspire Medical Systems press release (INSP): Q4 GAAP EPS of -$0.09 beats by $0.33.Revenue of $78.4M (+70.4% Y/Y) beats by $2.8M.Inspire expects full year 2022 revenue to be in

Accelerated Patient Demand and Increased Center Capacity Drives Year-over-Year Revenue Growth of 70% and 102% in the Fourth Quarter and Full Year, Respectively Accelerated Patient Demand and Increased

Accelerated Patient Demand and Increased Center Capacity Drives Year-over-Year Revenue Growth of 70% and 102% in the Fourth Quarter and Full Year, Respectively Accelerated Patient Demand and Increased Center Capacity Drives Year-over-Year Revenue Growth of 70% and 102% in the Fourth Quarter and Full Year, Respectively

Inspire (INSP) delivered earnings and revenue surprises of 80.85% and 0.27%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Axsome To Pay $312,500 To Settle Patent Infringement Litigation With Baudax Axsome Therapeutics, Inc.

Inspire Medical Systems (NYSE:INSP) is scheduled to announce Q4 earnings results on Tuesday, February 8th, after market close.The consensus EPS Estimate is -$0.46 and the consensus